SAFETY, TOLERABILITY AND PHARMACOKINETICS OF ONO-4474 IN HEALTHY SUBJECTS: A POTENTIAL THERAPY FOR PAIN IN OSTEOARTHRITIS

被引:0
作者
Conaghan, P. G. [1 ]
Duffy, K. [2 ]
Beale, D. [2 ]
Bruce, M. [2 ]
机构
[1] Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[2] Ono Pharma UK Ltd, London, England
关键词
D O I
10.1016/j.joca.2017.02.301
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
271
引用
收藏
页码:S174 / S174
页数:1
相关论文
共 50 条
  • [1] PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF LEMBOREXANT IN HEALTHY CHINESE SUBJECTS
    Moline, M.
    Nakai, K.
    Morita, M.
    Zhao, T.
    Takese, T.
    Cheng, J. Y.
    Yun, L.
    SLEEP MEDICINE, 2022, 100 : S132 - S133
  • [2] Pharmacokinetics, safety and tolerability of lasmiditan in healthy elderly subjects
    Wilbraham, D.
    Doty, E.
    Hochstetler, H.
    Yu, Y.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 447 - 447
  • [3] PHARMACOKINETICS, SAFETY AND TOLERABILITY OF BRIVARACETAM IN HEALTHY ELDERLY SUBJECTS
    Sargentini-Maier, M.
    Homery, M.
    Stockis, A.
    EPILEPSIA, 2009, 50 : 113 - 113
  • [4] PHARMACOKINETICS, SAFETY AND TOLERABILITY OF BRIVARACETAM IN HEALTHY ELDERLY SUBJECTS
    Sargentini-Maier, Maria Laura
    Homery, Marie-Claude
    Stockis, Armel
    EPILEPSIA, 2008, 49 : 452 - 452
  • [5] Pharmacokinetics, Safety, and Tolerability of Metformin in Healthy Elderly Subjects
    Jang, Kyungho
    Chung, Hyewon
    Yoon, Jang-soo
    Moon, Seol-Joo
    Yoon, Seo Hyun
    Yu, Kyung-Sang
    Kim, Kwangil
    Chung, Jae-Yong
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (09) : 1104 - 1110
  • [6] Lucerastat, an iminosugar with potential as substrate reduction therapy for glycolipid storage disorders: safety, tolerability, and pharmacokinetics in healthy subjects
    N. Guérard
    O. Morand
    J. Dingemanse
    Orphanet Journal of Rare Diseases, 12
  • [7] Lucerastat, an iminosugar with potential as substrate reduction therapy for glycolipid storage disorders: safety, tolerability, and pharmacokinetics in healthy subjects
    Guerard, N.
    Morand, O.
    Dingemanse, J.
    ORPHANET JOURNAL OF RARE DISEASES, 2017, 12
  • [8] Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Dupilumab in Healthy Adult Subjects
    Li, Zhaoyang
    Radin, Allen
    Li, Meng
    Hamilton, Jennifer D.
    Kajiwara, Miyuki
    Davis, John D.
    Takahashi, Yoshinori
    Hasegawa, Setsuo
    Ming, Jeffrey E.
    DiCioccio, A. Thomas
    Li, Yongtao
    Kovalenko, Pavel
    Lu, Qiang
    Ortemann-Renon, Catherine
    Ardeleanu, Marius
    Swanson, Brian N.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (06): : 742 - 755
  • [9] Seletracetam multiple dose safety, tolerability and pharmacokinetics in healthy subjects
    Leese, P. T.
    Hulhoven, R.
    Salas, E.
    Toublanc, N.
    Chen D, D.
    Sargentini-Maier, M. L.
    Stockis, A.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09) : 1079 - 1079
  • [10] The effect of fluvoxamine on the pharmacokinetics, safety, and tolerability of ramosetron in healthy subjects
    Kadokura, Takeshi
    den Adel, Martin
    Krauwinkel, Walter J. J.
    Takeshige, Tetsuo
    Nishida, Akito
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (07) : 691 - 695